Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:358-364

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aase, K.
Right arrow Articles by Eriksson, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aase, K.
Right arrow Articles by Eriksson, U.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Related Collections
Right arrow Chronic ischemic heart disease

(Circulation. 2001;104:358.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Vascular Endothelial Growth Factor-B–Deficient Mice Display an Atrial Conduction Defect

Karin Aase, PhD; Gabriel von Euler, PhD; Xuri Li, PhD; Annica Pontén, MS; Peter Thorén, MD, PhD; Renhai Cao, PhD; Yihai Cao, MD, PhD; Birgitta Olofsson, PhD; Samuel Gebre-Medhin, PhD; Milos Pekny, MD, PhD; Kari Alitalo, MD, PhD; Christer Betsholtz, MD, PhD; Ulf Eriksson, PhD

From the Ludwig Institute for Cancer Research, Stockholm Branch (K.A., G.v.E., X.L., A.P., B.O., U.E.); the Department of Physiology and Pharmacology, Section of Integrative Cardiovascular Physiology (P.T.) and Microbiology and Tumorbiology Center, Section of Angiogenesis Research (Y.C.), Karolinska Institutet, Stockholm; and the Department of Medical Biochemistry, University of Göteborg, Göteborg (S.G.-M., M.P., C.B.), Sweden; and the Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland (K.A.).

Correspondence to Ulf Eriksson, PhD, Ludwig Institute for Cancer Research, Stockholm Branch, Box 240, S-171 77 Stockholm, Sweden. E-mail ueri{at}licr.ki.se

Background— Vascular endothelial growth factors (VEGFs) and their receptors are essential regulators of vasculogenesis and angiogenesis in both embryos and adults. One of the factors with a still unknown physiological function is VEGF-B, which is expressed in many tissues, including the heart.

Methods and Results— Mice carrying a targeted deletion in the VEGF-B gene were developed. In VEGF-B-/- animals, no gross abnormalities were observed in organs that normally show high expression of VEGF-B, such as the heart, muscle, and kidney. Analysis of heart function by ECG showed that adult VEGF-B-/- mice have an atrial conduction abnormality characterized by a prolonged PQ interval. VEGF- or basic fibroblast growth factor–induced corneal angiogenesis was similar in normal and VEGF-B-/- mice.

Conclusions— VEGF-B seems to be required for normal heart function in adult animals but is not required for proper development of the cardiovascular system either during development or for angiogenesis in adults.


Key Words: growth substances • angiogenesis • electrocardiography • atrium • conduction




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E.-M. Hedlund, K. Hosaka, Z. Zhong, R. Cao, and Y. Cao
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
PNAS, October 13, 2009; 106(41): 17505 - 17510.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Zhang, Z. Tang, X. Hou, J. Lennartsson, Y. Li, A. W. Koch, P. Scotney, C. Lee, P. Arjunan, L. Dong, et al.
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
PNAS, April 14, 2009; 106(15): 6152 - 6157.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet
Role and Therapeutic Potential of VEGF in the Nervous System
Physiol Rev, April 1, 2009; 89(2): 607 - 648.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
Y. Cao
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
Sci. Signal., February 24, 2009; 2(59): re1 - re1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. E. Lahteenvuo, M. T. Lahteenvuo, A. Kivela, C. Rosenlew, A. Falkevall, J. Klar, T. Heikura, T. T. Rissanen, E. Vahakangas, P. Korpisalo, et al.
Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms
Circulation, February 17, 2009; 119(6): 845 - 856.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Schaper
The Renaissance of Vascular Endothelial Growth Factor, Part B
Circ. Res., October 24, 2008; 103(9): 903 - 904.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. Karpanen, M. Bry, H. M. Ollila, T. Seppanen-Laakso, E. Liimatta, H. Leskinen, R. Kivela, T. Helkamaa, M. Merentie, M. Jeltsch, et al.
Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy
Circ. Res., October 24, 2008; 103(9): 1018 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Poesen, D. Lambrechts, P. Van Damme, J. Dhondt, F. Bender, N. Frank, E. Bogaert, B. Claes, L. Heylen, A. Verheyen, et al.
Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration
J. Neurosci., October 15, 2008; 28(42): 10451 - 10459.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. Lisewski, Y. Shi, U. Wrackmeyer, R. Fischer, C. Chen, A. Schirdewan, R. Juttner, F. Rathjen, W. Poller, M. H. Radke, et al.
The tight junction protein CAR regulates cardiac conduction and cell-cell communication
J. Exp. Med., September 29, 2008; 205(10): 2369 - 2379.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Claesson-Welsh
VEGF-B Taken to Our Hearts: Specific Effect of VEGF-B in Myocardial Ischemia
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1575 - 1576.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Li, M. Tjwa, I. Van Hove, B. Enholm, E. Neven, K. Paavonen, M. Jeltsch, T. D. Juan, R. E. Sievers, E. Chorianopoulos, et al.
Reevaluation of the Role of VEGF-B Suggests a Restricted Role in the Revascularization of the Ischemic Myocardium
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1614 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Zheng, L. P. Christensen, and R. J. Tomanek
Differential effects of cyclic and static stretch on coronary microvascular endothelial cell receptors and vasculogenic/angiogenic responses
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H794 - H800.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. J. Tomanek, Y. Ishii, J. S. Holifield, C. L. Sjogren, H. K. Hansen, and T. Mikawa
VEGF Family Members Regulate Myocardial Tubulogenesis and Coronary Artery Formation in the Embryo
Circ. Res., April 14, 2006; 98(7): 947 - 953.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. K. Malik, M. E. Baldwin, F. Peale, G. Fuh, W.-C. Liang, H. Lowman, G. Meng, N. Ferrara, and H.-P. Gerber
Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice
Blood, January 15, 2006; 107(2): 550 - 557.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. W. Mould, S. A. Greco, M. M. Cahill, I. D. Tonks, D. Bellomo, C. Patterson, A. Zournazi, A. Nash, P. Scotney, N. K. Hayward, et al.
Transgenic Overexpression of Vascular Endothelial Growth Factor-B Isoforms by Endothelial Cells Potentiates Postnatal Vessel Growth In Vivo and In Vitro
Circ. Res., September 16, 2005; 97(6): e60 - e70.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen
The biology of vascular endothelial growth factors
Cardiovasc Res, February 15, 2005; 65(3): 550 - 563.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Hiratsuka, Y. Kataoka, K. Nakao, K. Nakamura, S. Morikawa, S. Tanaka, M. Katsuki, Y. Maru, and M. Shibuya
Vascular Endothelial Growth Factor A (VEGF-A) Is Involved in Guidance of VEGF Receptor-Positive Cells to the Anterior Portion of Early Embryos
Mol. Cell. Biol., January 1, 2005; 25(1): 355 - 363.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg
Comparative Evaluation of FGF-2-, VEGF-A-, and VEGF-C-Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability
Circ. Res., March 19, 2004; 94(5): 664 - 670.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Ponten, X. Li, P. Thoren, K. Aase, T. Sjoblom, A. Ostman, and U. Eriksson
Transgenic Overexpression of Platelet-Derived Growth Factor-C in the Mouse Heart Induces Cardiac Fibrosis, Hypertrophy, and Dilated Cardiomyopathy
Am. J. Pathol., August 1, 2003; 163(2): 673 - 682.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y.-s. Yoon and D. W. Losordo
All in the Family: VEGF-B Joins the Ranks of Proangiogenic Cytokines
Circ. Res., July 25, 2003; 93(2): 87 - 90.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Luttun and P. Carmeliet
De novo vasculogenesis in the heart
Cardiovasc Res, May 1, 2003; 58(2): 378 - 389.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. C Wanstall, A. Gambino, T. K Jeffery, M. M Cahill, D. Bellomo, N. K Hayward, and G. F Kay
Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension
Cardiovasc Res, August 1, 2002; 55(2): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. Jussila and K. Alitalo
Vascular Growth Factors and Lymphangiogenesis
Physiol Rev, July 1, 2002; 82(3): 673 - 700.
[Abstract] [Full Text] [PDF]